UL
NVO

Unionview LLC’s Novo Nordisk NVO Stock Holding History

Unionview LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,103
Closed -$250K – 93
2024
Q3 		$250K Buy
2,103
+61
+3% +$8.13K 0.19% 80
2024
Q2 		$291K Buy
2,042
+1
+0% +$133 0.24% 64
2024
Q1 		$262K Sell
2,041
-233
-10% -$27.7K 0.22% 69
2023
Q4 		$235K Sell
2,274
-205
-8% -$20.3K 0.21% 72
2023
Q3 		$225K Sell
2,479
-33
-1% -$2.91K 0.21% 74
2023
Q2 		$203K Buy
+2,512
New +$205K 0.19% 82

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Unionview LLC's NVO Position: Q4 2024 in Review

Unionview LLC sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,103 shares — an estimated $250K sold.

Unionview LLC first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $291K in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Unionview LLC reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Unionview LLC sold 2,103 Novo Nordisk shares in Q4 2024, an estimated $250K.
  • Unionview LLC first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • Unionview LLC's Novo Nordisk position peaked at $291K in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.